Buyon, J. P., et al. (2023). Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti‐SSA/Ro Pregnancies.

Indeed, 6 out of 10 cases of heart block were in mothers-to-be with extremely high blood anti-SSA/Ro antibody levels above 19,600 ELISA units per milliliter (the highest quartile of measurements ...

Heart rate monitoring may be a crucial means of detecting rhythm abnormalities in the fetuses of pregnant individuals who are positive for anti-Ro/SSA antibodies, according to data presented at ...

Fetuses exposed to anti-SSA (Sjögren’s) antibodies are at risk of developing irreversible complete atrioventricular block (CAVB), resulting in death or permanent cardiac pacing. Anti ...

Congenital heart block occurs in about 2% of pregnancies of women with anti-Ro/SSA antibodies, and it carries a serious risk of fetal illness or death. Almost all survivors of congenital heart ...

Source Reference: Buyon J, et al "Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA/Ro pregnancies" Arthritis ...

A clinical trial published in Arthritis & Rheumatology found that high levels of anti-Ro/SSA antibodies antibodies in pregnant women are associated with fetal atrioventricular block, which occurs ...

The presence of anti-SSA/RO antibodies in pregnant patients can predict adverse pregnancy outcomes, including spontaneous abortion, according to data derived from Sheng X, et al. Pediatr Rheumatol ...

Maternal anti-Ro/SSA and anti-La/SSB antibodies are associated with congenital heart block (CHB), a rare condition marked by damage to fetal cardiac conduction tissues and subsequent inflammation ...

The therapy reduced the likelihood that the disease recurred in a subsequent pregnancy by 50%, reducing tissue inflammation that is thought to injure the fetal heart. The findings of this study impact ...

Neonatal lupus is not true lupus. It is a rare condition associated with anti-SSA/Ro and/or anti-SSB/La antibodies from the mother that affect the fetus. At birth, the baby may have a skin rash, liver ...